@usstocksnews | YouTube | VK Видео | Чат
🔹 Revenue: $16.40B (Est. $16.18B) 🟢; +5% YoY
🔹 Adj. EPS: $2.04 (Est. $2.04) 🟡; +19% YoY
FY26 Guide:
🔹 Revenue: $65.50B–$67.00B (Est. $67.58B) 🔴
🔹 Adj. EPS: $5.00–$5.15 (Est. $5.63) 🔴
Segment Performance:
🔹 Pharmaceutical Sales: $14.84B; +6% YoY
🔹 Animal Health Sales: $1.51B; +8% YoY
Other Metrics:
🔹 KEYTRUDA/KEYTRUDA QLEX Sales: $8.37B; +7% YoY
🔹 GARDASIL/GARDASIL 9 Sales: $1.03B; -34% YoY
🔹 WINREVAIR Sales: $467.00M; +133% YoY
🔹 CAPVAXIVE Sales: $279.00M
🔹 FY25 Revenue: $65.01B; +1% YoY
🔹 FY25 Adj. EPS: $8.98
#mrk
Переходи в чат t.me/USstocksnews_chat
